BridgeBio Pharma, Inc. Insider Transactions
Purchase
Sell
BridgeBio Pharma, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Valantine Hannah
Director |
Sell | 12,875 @ $32.58 | $419.50 K | 1,764 | 03/06/2025 | 03/10/2025 | |
|
KKR Genetic Disorder L.P.
10 percent owner |
Sell | 6,000,000 @ $32.96 | $197.76 M | 19,260,971 | 03/05/2025 | 03/07/2025 | |
|
STEPHENSON BRIAN C
CFO and Treasurer |
Sell | 8,400 @ $33.18 | $278.70 K | 102,564 | 02/25/2025 | 02/27/2025 | |
|
Kumar Neil
CEO |
Sell | 37,899 @ $33.36 | $1.26 M | 5,060,548 | 02/25/2025 | 02/27/2025 | |
|
STEPHENSON BRIAN C
CFO and Treasurer |
Sell | 100 @ $34.18 | $3.42 K | 102,464 | 02/25/2025 | 02/27/2025 | |
|
Kumar Neil
CEO |
Sell | 37,101 @ $33.79 | $1.25 M | 5,023,447 | 02/25/2025 | 02/27/2025 | |
|
STEPHENSON BRIAN C
Secretary, Treasurer & CFO |
Sell | 4,148 @ $36.16 | $149.97 K | 102,464 | 02/19/2025 | 02/19/2025 | |
|
Kumar Neil
CEO |
Sell | 76 @ $36.56 | $2.78 K | 211,718 | 02/19/2025 | 02/19/2025 | |
|
Kumar Neil
CEO |
Sell | 31,467 @ $36.14 | $1.14 M | 211,794 | 02/19/2025 | 02/19/2025 | |
|
VIKING GLOBAL INVESTORS LP
10 percent owner |
Sell | 3,065,616 @ $34.90 | $106.99 M | 22,055,375 | 01/31/2025 | 01/31/2025 | |
|
Kumar Neil
CEO |
Sell | 4,000 @ $36.82 | $147.28 K | 5,098,447 | 01/29/2025 | 01/30/2025 | |
|
Kumar Neil
CEO |
Sell | 269,068 @ $36.34 | $9.78 M | 5,102,447 | 01/29/2025 | 01/30/2025 | |
|
Kumar Neil
CEO |
Sell | 326,932 @ $36.29 | $11.86 M | 5,371,515 | 01/28/2025 | 01/30/2025 | |
|
STEPHENSON BRIAN C
Secretary, Treasurer & CFO |
Sell | 68,000 @ $36.29 | $2.47 M | 93,758 | 01/28/2025 | 01/30/2025 | |
|
Kumar Neil
CEO |
Sell | 1,875 @ $22.76 | $42.68 K | 4,897,443 | 11/19/2024 | 11/20/2024 | |
|
Kumar Neil
CEO |
Sell | 25,514 @ $22.39 | $571.15 K | 4,899,318 | 11/19/2024 | 11/20/2024 | |
|
STEPHENSON BRIAN C
Secretary, Treasurer & CFO |
Sell | 4,156 @ $22.41 | $93.14 K | 93,758 | 11/19/2024 | 11/20/2024 | |
|
KKR Genetic Disorder L.P.
10 percent owner |
Sell | 5,800,000 @ $25.75 | $149.35 M | 25,260,971 | 09/13/2024 | 09/17/2024 | |
|
STEPHENSON BRIAN C
Secretary, Treasurer & CFO |
Sell | 1,698 @ $25.13 | $42.67 K | 85,192 | 08/19/2024 | 08/20/2024 | |
|
Kumar Neil
CEO |
Sell | 11,197 @ $25.13 | $281.37 K | 4,897,443 | 08/19/2024 | 08/20/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BridgeBio Pharma, Inc. FAQ's
The list of insiders at BridgeBio Pharma, Inc. includes Scott Randal W., STEPHENSON BRIAN C, Kumar Neil, KKR Genetic Disorder L.P., VIKING GLOBAL INVESTORS LP, Valantine Hannah.
Insiders have sold a total of 15.73 M BridgeBio Pharma, Inc. shares in the last 12 months for a total of 484.43 M sold.
The following insiders have sold BridgeBio Pharma, Inc. shares in the last 12 months: Scott Randal W. ($75.79 K), STEPHENSON BRIAN C ($3.10 M), Kumar Neil ($26.74 M), KKR Genetic Disorder L.P. ($347.11 M), VIKING GLOBAL INVESTORS LP ($106.99 M), Valantine Hannah ($419.50 K),